World’s first baby born with game-changing IVF method in Peru

In a groundbreaking moment for reproductive medicine, the world’s first baby was born in Peru using a new and innovative IVF treatment.

The baby was delivered at the Santa Isabel Clinic in Lima, Peru, using a cutting-edge method called Fertilo, developed by the US-based biotechnology company, Gameto, Caliber.Az reports referencing foreign media sources.

Fertilo is a new approach to in vitro fertilisation (IVF) that promises to be safer and more affordable for women compared to traditional IVF methods. In conventional IVF, women undergo superovulation — receiving high doses of hormones to stimulate the ovaries to produce multiple eggs. These eggs are then harvested, fertilized in a laboratory, and implanted as embryos. While effective, this process can be physically taxing and costly for many patients.

However, the Fertilo method works differently. It uses artificial ovaries to mature female eggs outside the body, removing the need for the intense hormonal stimulation that traditional IVF requires. The maturation process occurs in the lab, with eggs then fertilized or frozen for future use, similar to conventional IVF. This new technique can reduce the number of hormone injections by up to 80% and shorten the stimulation cycle to just three days, making the process less invasive and emotionally taxing.

A mother who gave birth using Fertilo shared her positive experience, saying, “Fertilo’s innovative approach eased the physical experience as well as the emotional burden of many hormone injections.”

The birth of this baby marks a significant achievement in the IVF field, over 45 years after the first IVF baby, Louise Brown, was born in 1978. Since then, more than 10 million babies have been born globally using traditional IVF techniques.

Gameto's Fertilo technology has already been authorized for use in countries like Australia, Japan, Mexico, Argentina, and Paraguay. In the United States, clinical trials are currently underway, with hopes that the method will soon be available to even more patients seeking fertility treatment.

By Tamilla Hasanova